Cargando…

Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemia

In a phase IV trial, 84 patients (age 18–79) with acute myeloid leukemia (AML) in first complete remission (CR) received cycles of immunotherapy with histamine dihydrochloride (HDC) and low-dose human recombinant interleukin 2 (IL-2) for 18 months to prevent leukemic relapse. During cycles, the trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martner, Anna, Rydström, Anna, Riise, Rebecca E, Aurelius, Johan, Anderson, Harald, Brune, Mats, Foà, Robin, Hellstrand, Kristoffer, Thorén, Fredrik B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760300/ https://www.ncbi.nlm.nih.gov/pubmed/26942055 http://dx.doi.org/10.1080/2162402X.2015.1041701

Ejemplares similares

Dynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemia
por: Sander, Frida Ewald, et al.
Publicado: (2016)

NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance
por: Martner, Anna, et al.
Publicado: (2015)

Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy
por: Sander, Frida Ewald, et al.
Publicado: (2017)

Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia
por: Bernson, E, et al.
Publicado: (2017)

Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype
por: Nilsson, Malin S., et al.
Publicado: (2019)

Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse‐preventive immunotherapy in acute myeloid leukaemia
por: Nilsson, Malin S., et al.
Publicado: (2019)

Reactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL cells
por: Werlenius, Olle, et al.
Publicado: (2016)

Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia
por: Hussein, Brwa Ali, et al.
Publicado: (2021)

Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia
por: Hussein, Brwa Ali, et al.
Publicado: (2022)

Role of the ERK Pathway for Oxidant-Induced Parthanatos in Human Lymphocytes
por: Akhiani, Ali A., et al.
Publicado: (2014)

Impact of IL-1β and the IL-1R antagonist on relapse risk and survival in AML patients undergoing immunotherapy for remission maintenance
por: Grauers Wiktorin, Hanna, et al.
Publicado: (2021)

Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
por: Grauers Wiktorin, Hanna, et al.
Publicado: (2018)

Anti-Leukemic Properties of Histamine in Monocytic Leukemia: The Role of NOX2
por: Kiffin, Roberta, et al.
Publicado: (2018)

HLA-B*44 and the Bw4-80T motif are associated with poor outcome of relapse-preventive immunotherapy in acute myeloid leukemia
por: Komic, Hana, et al.
Publicado: (2023)

NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells
por: Hussein, Brwa Ali, et al.
Publicado: (2023)

Natural killer cell-based immunotherapy for acute myeloid leukemia
por: Xu, Jing, et al.
Publicado: (2020)

Interactions of Human Myeloid Cells with Natural Killer Cell Subsets In Vitro and In Vivo
por: Chijioke, Obinna, et al.
Publicado: (2011)

NOX2 in autoimmunity, tumor growth and metastasis
por: Martner, Anna, et al.
Publicado: (2018)

Natural Killer T Cells Subsets in Cancer, Functional Defects in Prostate Cancer and Implications for Immunotherapy
por: Nowak, Michael, et al.
Publicado: (2011)

Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy
por: Gaggero, Silvia, et al.
Publicado: (2021)

Natural Killer Cells and Immunotherapy
por: Noh, Ji-Yoon, et al.
Publicado: (2023)

Cytotoxic activity and subset populations of peripheral blood natural killer cells in patients with chronic pain
por: Yoon, Jae Joon, et al.
Publicado: (2018)

Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer
por: Iyoda, Tomonori, et al.
Publicado: (2023)

Natural Killer Cell Immunotherapy: From Bench to Bedside
por: Domogala, Anna, et al.
Publicado: (2015)

Frequency and phenotype of natural killer cells and natural killer cell subsets in bovine lymphoid compartments and blood
por: Hamilton, Carly A., et al.
Publicado: (2017)

Characterization of tumor infiltrating Natural Killer cell subset
por: Levi, Inbar, et al.
Publicado: (2015)

The role of natural killer cells in chronic myeloid leukemia
por: Danier, Anna Carolyna Araújo, et al.
Publicado: (2011)

Natural Killer T Cells in Cancer Immunotherapy
por: Nair, Shiny, et al.
Publicado: (2017)

Natural killer cell immunotherapy in glioblastoma
por: Hosseinalizadeh, Hamed, et al.
Publicado: (2022)

Natural killer cells in tumor immunotherapy
por: Wang, Dongyao, et al.
Publicado: (2023)

NOX2-Derived Reactive Oxygen Species in Cancer
por: Grauers Wiktorin, Hanna, et al.
Publicado: (2020)

The More, The Better: “Do the Right Thing” For Natural Killer Immunotherapy in Acute Myeloid Leukemia
por: Parisi, Sarah, et al.
Publicado: (2017)

Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy
por: Joshi, Shweta, et al.
Publicado: (2022)

IFNL4 Genotypes Predict Clearance of RNA Viruses in Rwandan Children With Upper Respiratory Tract Infections
por: Rugwizangoga, Belson, et al.
Publicado: (2019)

Liver natural killer cells: subsets and roles in liver immunity
por: Peng, Hui, et al.
Publicado: (2016)

Impaired natural killer cell subset phenotypes in human obesity
por: Bähr, Ina, et al.
Publicado: (2018)

Role of Distinct Natural Killer Cell Subsets in Anticancer Response
por: Stabile, Helena, et al.
Publicado: (2017)

NCR1 Expression Identifies Canine Natural Killer Cell Subsets with Phenotypic Similarity to Human Natural Killer Cells
por: Foltz, Jennifer A., et al.
Publicado: (2016)

Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies
por: Seidel, Ursula J. E., et al.
Publicado: (2013)

Non-Genetically Improving the Natural Cytotoxicity of Natural Killer (NK) Cells
por: Villalba, Martin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4ddd4u9qg6ccs9sddp4rj5etj0